| Trade Names: | |
| Synonyms: | |
| Status: | Approved (1994) |
| Entry Type: | Oligosaccharide |
| Molecule Category: | Salt |
| UNII: | 12M44VTJ7B |
| Parent Compound: | DALTEPARIN |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| ACTIVATOR | Antithrombin-III activator | FDA |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Venous Thromboembolism | 4 | D054556 | ClinicalTrials |
| Severe Acute Respiratory Syndrome | 3 | D045169 | ClinicalTrials |
| Renal Insufficiency, Chronic | 3 | D051436 | ClinicalTrials |
| Thromboembolism | 3 | D013923 | ClinicalTrials |
| Breast Neoplasms | 3 | D001943 | ClinicalTrials |
| Prostatic Neoplasms, Castration-Resistant | 3 | D064129 | ClinicalTrials |
| Lung Neoplasms | 3 | D008175 | ClinicalTrials |
| Hepatic Veno-Occlusive Disease | 3 | D006504 | ClinicalTrials |
| Brain Injuries | 3 | D001930 | ClinicalTrials |
| Stroke | 3 | D020521 | ClinicalTrials |
| Pregnancy | 3 | D011247 | ClinicalTrials |
| Abortion, Habitual | 3 | D000026 | ClinicalTrials |
| Colorectal Neoplasms | 3 | D015179 | ClinicalTrials |
| Thrombophilia | 3 | D019851 | ClinicalTrials |
| Pancreatic Neoplasms | 3 | D010190 | ClinicalTrials |
| Diabetic Foot | 2 | D017719 | ClinicalTrials |
| Ovarian Neoplasms | 2 | D010051 | ClinicalTrials |
| Central Nervous System Neoplasms | 2 | D016543 | ClinicalTrials |
| Anemia, Sickle Cell | 2 | D000755 | ClinicalTrials |
| Shock, Septic | 2 | D012772 | ClinicalTrials |
| Multiple Myeloma | 2 | D009101 | ClinicalTrials |
| Carcinoma, Renal Cell | 1 | D002292 | ClinicalTrials |
Related Entries
Adverse Reactions
System Organ Classification (SOC)
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL1201460 |
| FDA SRS | 12M44VTJ7B |
CONTENTS